Mirum Pharmaceuticals is a company creating therapies for patients with liver diseases. The company specializes in Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC). It aims to address the underlying cause of symptoms and liver damage with the approach based on data from clinical trials.
|HQ||Foster City, US||Map|
Net income (Q2, 2020)
EBIT (Q2, 2020)
Market capitalization (20-Nov-2020)
Closing stock price (20-Nov-2020)
|Company Name||Date||Deal Size|
|Mirum Pharmaceuticals AG|
Mirum Pharmaceuticals has 194 Twitter Followers. The number of followers has increased 48.9% month over month and increased 71.4% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Mirum Pharmaceuticals founded?
Mirum Pharmaceuticals was founded in 2018.
Who are Mirum Pharmaceuticals key executives?
Mirum Pharmaceuticals's key executives are Chris Peetz, Laura Brege and Ian Clements.
How many employees does Mirum Pharmaceuticals have?
Mirum Pharmaceuticals has 24 employees.
Who are Mirum Pharmaceuticals competitors?
Competitors of Mirum Pharmaceuticals include Vericel, MCRC and Quellis Biosciences.
Where is Mirum Pharmaceuticals headquarters?
Mirum Pharmaceuticals headquarters is located at 950 Tower Ln #1050, Foster City.
Where are Mirum Pharmaceuticals offices?
Mirum Pharmaceuticals has an office in Foster City.
How many offices does Mirum Pharmaceuticals have?
Mirum Pharmaceuticals has 1 office.
Receive alerts for 300+ data fields across thousands of companies